(1)
A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT QTc Intervals in Adult Healthy Volunteers. J of Skin 2020, 4 (6), s109. https://doi.org/10.25251/skin.4.supp.109.